Breast Cancer

New England Journal of Medicine

Volumn 327, Issue 6, 1992, Pages 390-398

  Harris, Jay R ^a   Lippman, Marc E ^b   Veronesi, Umberto ^c   Willett, Walter ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST; BREAST TUMOR; CANCER INVASION; CARCINOMA IN SITU; FEMALE; HUMAN; MASTECTOMY; PAGET NIPPLE DISEASE; PATHOLOGY; PLASTIC SURGERY; REVIEW; ASPIRATION BIOPSY; AXILLARY LYMPH NODE; BREAST CANCER; BREAST PROSTHESIS; BREAST RECONSTRUCTION; CANCER STAGING; CHEMOTHERAPY; HISTOLOGY; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MENSTRUAL CYCLE; METASTASIS; MICROSCOPY; PRIORITY JOURNAL;

BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMAN; MASTECTOMY; NEOPLASM INVASIVENESS; SURGERY, PLASTIC;

EID: 0027113860     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199208063270606     Document Type: Review

References (76)

1. Staging for carcinoma of the breast. In: Beahrs O, Henson D, Hutter R, Myers M, eds. Manual for staging of cancer. 3rd ed. Philadelphia: J.B. Lippincott, 1988:145–50.
2. Stomper PC, Connolly JL, Meyer JE, Harris JR. Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation. Radiology 1989; 172: 235–41.
3. Meyer JS. Cell kinetics of histologic variants of in situ breast carcinoma. Breast Cancer Res Treat 1986; 7: 171–80.
4. Lodato RF, Maguire HC Jr, Greene MI, Weiner DB, LiVolsi VA. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Mod Pathol 1990; 3: 449–54.
5. Bartkova J, Barnes DM, Millis RR, Gullick WJ. Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ. Hum Pathol 1990; 21: 1164–7.
6. Patchefsky AS, Schwartz GF, Finkelstein SD, et al. Heterogeneity of intraductal carcinoma of the breast. Cancer 1989; 63: 731–41.
7. Holland R, Hendriks JHCL, Verbeek ALM, Mravunac M, Schuurmans Stekhoven JH. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990; 335: 519–22.
8. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol 1991; 15: 209–21.
9. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982; 50: 1309–14.
10. Andersen J, Nielsen M, Christensen L. New aspects of the natural history of in situ and invasive carcinoma in the female breast: results from autopsy investigations. Verh Dtsch Ges Pathol 1985; 69: 88–95.
11. Bartow SA, Pathak DR, Black WC, Key CR, Teaf SR. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer: a forensic autopsy study. Cancer 1987; 60: 2751–60.
12. Alpers CE, Wellings SR. The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol 1985; 16: 796–807.
13. Rosen PP, Braun DW Jr, Kinne DE. The clinical significance of preinvasive breast carcinoma. Cancer 1980; 46: Suppl: 919–25.
14. Page DL, Duport WD, Rogers LW, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 1982; 49: 751–8.
15. Robbins GF, Berg JW. Bilateral primary breast cancers: a prospective clinicopathological study. Cancer 1964; 17: 1501–27.
16. Lagios MD, Margolin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989; 63: 618–24.
17. Kinne DW, Petrek JA, Osborne MP, Fracchia AA, DePalo AA, Rosen pp. Breast carcinoma in situ. Arch Surg 1989; 124: 33–6.
18. Silverstein MJ, Waisman JR, Gierson ED, Colburn W, Gamagami P, Lewinsky BS. Radiation therapy for intraductal carcinoma: is it an equal alternative? Arch Surg 1991; 126: 424–8.
19. Fisher ER, Leeming R, Anderson S, Redmond C, Fisher B. Conservative management of intraductal carcinoma (DCIS) of the breast. J Surg Oncol 1991; 47: 139–47.
20. Price P, Sinnett HD, Gusterson B, Walsh G, A'Hern RP, McKinna JA. Duct carcinoma in situ: predictors of local recurrence and progression in patients treated by surgery alone. Br J Cancer 1990; 61: 869–72.
21. Graham MD, Lakhani S, Gazet JC. Breast conserving surgery in the management of in situ breast carcinoma. Eur J Surg Oncol 1991; 17: 258–64.
22. Solin LJ, Recht A, Fourquet A, et al. Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Cancer 1991; 68: 2337–44.
23. Schwartz GF, Feig SA, Rosenberg AL, Patchefsky AS, Schwartz AB. Staging and treatment of clinically occult breast cancer. Cancer 1984; 53: 1379–84.
24. Wheeler JE, Enterline HT, Roseman JM, et al. Lobular carcinoma in situ of the breast: long-term follow-up. Cancer 1974; 34: 554–63.
25. Frykberg ER, Santiago F, Betsill WL Jr, O'Brien PH. Lobular carcinoma in situ of the breast. Surg Gynecol Obstet 1987; 164: 285–301.
26. Lemanne D, Simone M, Martino S, Swanson M. Breast carcinoma in situ (CIS): greater rise in ductal carcinoma in situ (DCIS) vs. lobular carcinoma in situ (LCIS). Proc Am Soc Clin Oncol 1991; 10: 45. abstract.
27. Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991; 22: 1232–9.
28. Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW Jr. Lobular carcinoma in situ of the breast: detailed analysis of 99 patients with average follow-up of 24 cases. Am J Surg Pathol 1978; 2: 225–51.
29. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978; 42: 737–69.
30. Andersen JA. Lobular carcinoma in situ: a long-term follow-up in 52 cases. Acta Pathol Microbiol Scand [A] 1974; 82: 519–33.
31. Harris M, Howell A, Chrissohou M, Swindell RI, Hudson M, Sellwood RA. A comparison of metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer 1984; 50: 23–30.
32. Fisher ER, Kenny JP, Sass R, Dimitrov NV, Siderits RH, Fisher B. Medullary cancer of the breast revisited. Breast Cancer Res Treat 1990; 16: 215–29.
33. Fisher B, Bauer M, Wickerham DL, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update. Cancer 1983; 52: 1551–7.
34. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63: 181–7.
35. Cancer Research Campaign Working Party. Cancer Research Campaign (King's/Cambridge) Trial for Early Breast Cancer: a detailed update at the tenth year. Lancet 1980; 2: 55–60.
36. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674–81.
37. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989; 320: 822–8.
38. Veronesi U, Banfi A, Salvadori B, et al. Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer 1990; 26: 668–70.
39. Hayward J, Caleffi M. The significance of local control in the primary treatment of breast cancer. Arch Surg 1987; 122: 1244–7.
40. Sarrazin D, Le MG, Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989; 14: 177–84.
41. von Dongen JA, Bartelink H, Fentiman IS, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. In: Consensus development conference on the treatment of early-stage breast cancer. Journal of the National Cancer Institute monographs. No. 11. Washington, D.C.: Government Printing Office, 1992:15–8. (NIH publication no. 90–3187.)
42. Straus K, Lichter A, Lippman M, et al. Results of the National Cancer Institute Early Breast Cancer Trial. In: Consensus development conference on the treatment of early-stage breast cancer. Journal of the National Cancer Institute monographs. No. 11. Washington, D.C.: Government Printing Office, :27–32. (NIH publication no. 90–3187.)
43. Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. In: Consensus development conference on the treatment of early-stage breast cancer. Journal of the National Cancer Institute monographs. No. 11. Washington, D.C.: Government Printing Office, 1992:19–25. (NIH publication no. 90–3187.)
44. Vicini FA, Recht A, Abner A, et al. Recurrence in the breast following conservative surgery and radiation therapy for early-stage breast cancer. In: Consensus development conference on the treatment of early-stage breast cancer. Journal of the National Cancer Institute monographs. No. 11. Washington, D.C.: Government Printing Office, 1992:33–9. (NIH publication no. 90–3187.)
45. Clark RM, Wilkinson RH, Miceli PN, MacDonald WD. Breast cancer: experiences with conservation therapy. Am J Clin Oncol 1987; 10: 461–8.
46. Spitalier JM, Gambarelli J, Brandone H, et al. Breast-conserving surgery with radiation therapy for operable mammary carcinoma: a 25-year experience. World J Surg 1986; 10: 1014–20.
47. Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 1989; 17: 719–25.
48. Treatment of early-stage breast cancer. JAMA 1991; 265: 391–5.
49. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1–2 breast carcinomas: implications for clinical trials of breast-conserving surgery. Cancer 1985; 56: 979–90.
50. Fisher ER, Sass R, Fisher B, Wickerham L, Paik SM. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS). Cancer 1986; 57: 197–208.
51. Holland R, Connolly JL, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1991; 8: 113–8.
52. Boyages J, Recht A, Connolly JL, et al. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 1990; 19: 29–41.
53. Veronesi U, Volterrani F, Luini A, et al. Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 1990; 26: 671–3.
54. Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991; 338: 327–31.
55. Carter D. Margins of “lumpectomy” for breast cancer. Hum Pathol 1986; 17: 330–2.
56. Solin LJ, Fowble BL, Schultz DJ, Goodman RL. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 1991; 21: 279–87.
57. Vicini FA, Eberlein TJ, Connolly JL, et al. The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg 1991; 214: 200–4.
58. Uppsala-Orebro Breast Cancer Study Group. Sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Natl Cancer Inst 1990; 82: 277–82.
59. Hammond S, Keyhani-Rofagha S, O'Toole RV. Statistical analysis of fine needle aspiration cytology of the breast: a review of 678 cases plus 4,265 cases from the literature. Acta Cytol 1987; 31: 276–80.
60. Goldie JH, Coldman AJ. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979; 63: 1727–33.
61. DeWyss WD. Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor-related systemic growth-retarding factors. Cancer Res 1972; 32: 374–9.
62. Fisher B, Gunduz N, Saffer EA. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 1983; 43: 1488–92.
63. Bonadonna G, Veronesi U, Brambilla C, et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 1990; 82: 1539–45.
64. Mauriac L, Durand M, Avril A, Dilhuydy J-M. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm: results of a randomized trial in a single centre. Ann Oncol 1991; 2: 347–54.
65. Jacquillat C, Weil M, Baillet F, et al. Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 1990; 66: 119–29.
66. Hrushesky WJM, Bluming AZ, Gruber SA, Sothern RB. Menstrual influence on surgical cure of breast cancer. Lancet 1989; 2: 949–52.
67. Ratajczak HV, Sothern RB, Hrushesky WJ. Estrous influence on surgical cure of a mouse breast cancer. J Exp Med 1988; 168: 73–83.
68. Badwe RA, Gregory WM, Chaudary MA, et al. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet 1991; 337: 1261–4.
69. Senie RT, Rosen PP, Rhodes P, Lesser ML. Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. Ann Intern Med 1991; 115: 337–42.
70. McGuire WL. The optimal timing of mastectomy: low tide or high tide? Ann Intern Med 1991; 115: 401–3.
71. Schain WS, Jacobs E, Wellisch DK. Psychosocial issues in breast reconstruction: intrapsychic, interpersonal, and practical concerns. Clin Plast Surg 1984; 11: 237–51.
72. Goldwyn RM. Breast reconstruction after mastectomy. N Engl J Med 1987; 317: 1711–4.
73. Radovan C. Breast reconstruction after mastectomy using the temporary expander. Plast Reconstr Surg 1982; 69: 15–208.
74. Kessler DA. The basis of the FDA's decision on breast implants. N Engl J Med 1992; 326: 1713–5.
75. Angell M. Breast implants — protection or paternalism? N Engl J Med 1992; 326: 1695–6.
76. Fisher JC. The silicone controversy — when will science prevail? N Engl J Med 1992; 326: 1696–8.